Calidi Biotherapeutics, Inc. — Form D

Calidi Biotherapeutics, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-06-29. The offering totals $25.0M, of which $5.0M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2023-06-29
• Form: D
• Accession: 0001709409-23-000007
• Industry: Biotechnology
• Exemptions: 06c
• Total offering: $25.0M
• Amount sold: $5.0M
• Remaining: $20.0M
• Investors: 1
• Date of first sale: 2023-06-20
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-485625

Issuer

• Name: Calidi Biotherapeutics, Inc.
• CIK: 0001758478
• Entity type: Corporation
• Jurisdiction: NEVADA
• Address: 4475 Executive Drive, Suite 200, San Diego, CA, 92121
• Phone: 858-794-9600

Officers, directors & promoters (14)

More

• CIK 1758478 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search